Epilepsy is a chronic brain disease affecting millions of individuals. Kainate receptors, especially kainate-type of ionotropic glutamate receptor 2 (GluK2), play an important role in epileptogenesis. Recent data showed that GluK2 could undergo post-translational modifications in terms of S-nitrosylation (SNO), and affect the signaling pathway of cell death in cerebral ischemia-reperfusion. However, it is unclear whether S-nitrosylation of GluK2 (SNO-GluK2) contributes to cell death induced by epilepsy. Here, we report that kainic acid-induced SNO-GluK2 is mediated by GluK2 itself, regulated by neuronal nitric oxide synthase (nNOS) and the level of cytoplasmic calcium in vivo and in vitro hippocampus neurons. The wholecell patch clamp recordings showed the influence of SNOGluK2 on ion channel characterization of GluK2-Kainate receptors. Moreover, immunohistochemistry staining results showed that inhibition of SNO-GluK2 by blocking nNOS or GluK2 or by reducing the level of cytoplasmic calciumprotected hippocampal neurons from kainic acid-induced injury. Finally, immunoprecipitation and western blotting data revealed the involvement of assembly of a GluK2-PSD95-nNOS signaling complex in epilepsy. Taken together, our results showed that the SNO-GluK2 plays an important role in neuronal injury of epileptic rats by forming GluK2-PSD95-nNOS signaling module in a cytoplasmic calciumdependent way, suggesting a potential therapeutic target site for epilepsy.
Epilepsy is a chronic neurological disease with a prominent feature of spontaneous recurrent seizures. With significant development of antiepileptic drugs, the majority of epilepsy can be controlled. Only 20-30% of epilepsy develops refractory epilepsy, and at that moment the surgery is often used (Rao and Lowenstein 2015) . Temporal lobe epilepsy is the most frequent type in adults, which is often accompanied with unilateral epileptic foci lesions (Carta et al. 2014) . There are significant histopathologic changes in the hippocampus because of temporal lobe epilepsy, including neuronal loss of cornu ammonis area 1 (CA1) and 3 (CA3) (Negrete-Diaz et al. 2007) , sclerosis hyperplasia, and abnormal mossy fiber sprouting of granule cell in dentate gyrus (Carta et al. 2014; Crepel and Mulle 2015) .
Although epilepsy has been extensively investigated in the past decades, the precise mechanisms are still unclear. Initially, the kainate-type of ionotropic glutamate receptor 2 (GluK2)-containing kainate receptors (GluK2-KARs) is regarded as receptor-operated channels for ions and neurotransmitter (Hollmann and Heinemann 1994; Lerma et al. 2001; Contractor et al. 2011; Rodriguez-Moreno and Sihra 2013) . Recently, mounting evidence indicates the role of GluK2-KARs in the pathogenesis of neurological diseases, such as epilepsy (Sattler and Tymianski 2001; Nakamura et al. 2007) . It is well-known that kainic acid (KA) administration can induce seizure. Conversely, in the context of GluK2 knockout, the KA-related susceptibility is remarkably reduced (Mulle et al. 1998; Peret et al. 2014) . Moreover, Ouardouz et al. (2009) showed a key role of GluK2-KARs in loss of axonal function after glutamate exposure by participating in the formation of novel signaling complexes and releasing toxic amounts of Ca 2+ and nitric oxide (NO). This view was further supported by one subsequent study (Negrete-Diaz et al. 2006; Vincent and Mulle 2009; Andrade-Talavera et al. 2012 ) that activation of KARs, especially GluK2-KARs, leads to a local depolarization, opening of L-type voltage-gated calcium channels (LVGCCs), activation of ryanodine receptors (RyRs) on endoplasmic reticulum (ER), and then the release of considerable Ca 2+ into the cytoplasm (Miyazaki and Ross 2013) . Taken together, there is a potential connection between GluK2 and epilepsy. However, the detailed mechanisms underlying the association of GluK2 and epilepsy remain to be investigated.
Increasing studies focused on post-translational modifications of proteins, for instance, S-nitrosylation of proteins mediated by NO, which exerts an important effect on the regulation of protein functions (Hess et al. 2005) . As an example of cGMP-independent actions, nitroso-covalent binding to the critical cysteine thiol, namely S-nitrosylation (SNO), has been demonstrated to be of importance in the regulation of protein functions (Ahern et al. 2002; Nakamura et al. 2015) . There is evidence that production of NO catalyzed by neuronal NO synthase (nNOS) facilitates S-nitrosylation of GluK2 (SNO-GluK2) after cerebral ischemia/reperfusion (I/R). This S-nitrosylation can be mediated by the assembly of N-methyl-D-aspartate receptors (NMDARs), post-synaptic density protein 95 (PSD95), and nNOS, which subsequently activates Jun N-terminal kinase downstream pathway via up-regulating the assembly of GluK2-PSD95-mixed lineage kinase 3 (Yu et al. 2008; Di et al. 2012) .
Given the importance of GluR6 in epilepsy, it is unclear whether SNO-GluK2 is involved in epileptogenesis, and how the level of intracellular calcium regulates SNO-GluK2. To this end, using cultured hippocampal neurons in vitro condition and KA-induced epileptic animal models in vivo condition, our study focused on how the cytoplasmic calcium level affected SNO-GluK2 in the hippocampal neurons, GluK2-mediated whole-cell current, as well as epilepsyinduced hippocampal damage. Taken together, our results will not only deepen the understanding about the pathogenesis of epilepsy, but also provide a new target for epilepsy and other relevant neurological diseases.
Materials and methods
Primary hippocampal neuron culture Primary hippocampal cultures were established from SpragueDawley rats (Cavens company, Changzhou, Jiangsu, China, RRID: RGD_1566457) on 18th embryonic day according to previous reports with minor modifications (Mattson et al. 1989; Qiu et al. 2011) . Briefly, the hippocampus was excavated and dissociated by 0.25% (w/v) trypsin (Amresco, Solon, OH, USA) at the temperature of 37°C and terminated by Dulbecco's modified Eagle's medium (GIBCO-BRL, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum. After centrifugation (1000 g 9 5 min), the precipitate was suspended with neurobasal A medium (Invitrogen, Carlsbad, CA, USA), supplemented with 0.5 mM L-glutamine, 25 lM glutamic acid, 25 lM 2-mercaptoethanol, and 2% B27, and then seeded on cells with 12-mm-diameter round coverslips coated by poly-D-lysine (0.1 mg/mL) at a density of 0.5 9 10 5 /cm 2 . On third day after seeding, the seeding medium was half-changed by maintenance medium (neurobasal A medium supplemented with 2% B27, 0.5 mM L-glutamine, and 25 lM 2-mercaptoethanol), and then half-changed by maintenance medium twice a week. Cultures were kept in a 5% CO 2 incubator at the temperature of 37°C. The cultures on 19 days in vitro were used for subsequent experiments. The duration and time points of treatment with KA or other drugs are specified in the 'Results' section.
Measurement of S-nitrosylation S-nitrosylation was measured by employing 'Biotin-Switch' assay as described by Jaffrey et al. (2001) . Briefly, the free thiols of S-nitrosylated proteins (800 lg) were inhibited by methylation with methyl methanethiosulfonate. Unreacted methyl methanethiosulfonate was eliminated by protein precipitation in acetone (10 volumes) at a temperature of À20°C. The cysteine residues S-nitrosylated by NO-Cbl were modified to free thiols with 1 mM final concentration of sodium ascorbate, without altering the methylated thiols. The samples were then mixed with biotin-hexyl pyridyldithiopropionamide for 1 h at the 25°C so that the reduced thiols were covalently linked to biotin derivatives. The biotinylated proteins were acetone-precipitated and then re-suspended, followed by addition of neutralization buffer (two volumes). This resultant production was then incubated overnight with streptavidin-agarose slurry, eluted from the beads with a special solution (pH = 7.7) containing 20 mM HEPES-NaOH, 100 mM 2-mercaptoethanol, 1 mM EDTA, and 100 mM NaCl, and eventually subjected to western blotting analysis.
Western blotting analysis
Samples were electrophoresed through a 7.5-10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and blotted to nitrocellulose or polyvinylidene fluoride membrane. After blocking, the membranes were incubated with the following primary antibodies: rabbit anti-GluK2 (1 : 1000, AGC-009; Alomone Labs, Jerusalem, Israel, RRID: AB_2039898), mouse b-actin (1 : 2000, ab8226; Abcam, Cambridge, UK, RRID: AB_2536844), mouse anti-PSD95 (1 : 1000, ab18258; Abcam, RRID: AB_444362), and rabbit antinNOS (1 : 1000, #4234; Cell Signaling Technology, Beverly, MA, USA, RRID: AB_2152488) in triethanolamine-buffered saline solution with 0.05% Tween-20 (TBS-T) and 1% bovine serum albumin overnight at 4°C and then washed three times by TBS-T. Secondary anti-mouse or anti-rabbit antibodies (purchased from Cell Signaling) were used at a dilution of 1 : 1000. The membranes (Figs 1 and 2) were incubated with alkaline phosphatase-conjugated secondary antibodies in TBS-T for 2 h and developed using nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate color substrate (Promega, Madison, WI, USA). The polyvinylidene fluoride membranes (Figs 4, 5, and 7) were incubated with horseradish peroxidase-conjugated secondary antibodies and visualized by the enhanced chemiluminescence detection reagents (Pierce, Rockford, IL, USA) and photographic films. For quantifications, the density of all bands was then scanned and analyzed with an Image analyzer (LabWorks Software; UVP, Upland, CA, USA).
Patch clamp recording
The electrophysiological recordings were carried out in the conventional whole-cell patch-recording configuration under voltage-clamp conditions Zhang et al. 2012) . Patch pipettes were made from glass capillaries with an outer diameter of 1.5 mm on a two-stage puller (PP-830; Narishige, Tokyo, Japan). Cultured neurons were bathed in a solution (pH7.4, 320 mOsm/L) containing 150 mM NaCl, 1 mM MgCl 2 , 5 mM KCl, 2 mM CaCl 2 , 10 mM HEPES, and 10 mM glucose at 25°C. Whole-cell recordings were held at À80 to À50 mV throughout the experiment. Recording pipettes (resistance 2-4 MΩ) were filled with a solution (pH7.2, 310 mOsm/L) containing 122 mM CsCl, 2 mM NaCl, 2 mM MgCl 2 , 10 mM EGTA, 10 mM HEPES, 4 mM Na 2 ATP, and 0.06 mM spermine.
Animals and treatment
Adult Sprague-Dawley rats (male) weighing 250 AE 10 g were purchased from Cavens (RRID: RGD_1566457) and maintained under specific pathogen-free conditions. All animal were treated according to protocols approved by Institutional Animal Care and Use committee (IACUC) of Nanjing Medical University and Changzhou No.2 People's Hospital ethics committee (No. 00012014120103). Methods depicted below were all performed in accordance with the relevant guidelines and regulations by our institutional review board.
KA-induced seizure was established as described previously (Zhang et al. 2011) . Briefly, following an intracerebroventricular (i.c.v) injection of 0.6 lg/10 ll KA to rats, behavioral changes in limbic motor seizures were scored according to Racine (Racine 1972) . The control animals underwent the same anesthesia and surgical procedures except KA infusion. The rats were randomly assigned into groups: (i) control, (ii) KA, (iii) Drugs + KA, (iv) KA + Vehicle using a completely randomized digital table. To minimize animal suffering, rats were anesthetized with 2% isoflurane across the surgical procedure. Additionally, 2 h after KAinduced seizure, the anti-convulsant drug diazepam (2 mg/kg) was injected intraperitoneally to terminate seizures.
All drugs in this study were obtained from Sigma-Aldrich Company (St. Louis, MO, USA) unless mentioned elsewhere. The treatment of drugs is specified in the 'Results' section. Tat-GluK2-9c (Arg-Leu-Pro-Gly-Lys-Glu-Thr-Met-Ala) was a GluK2 C-terminuscontaining peptide conjugated to Tat protein (Tyr-Gly-Arg-Lys-LysArg-Arg-Gln-Arg-Arg-Arg) as previously described Pei et al. 2006) . The sequence for PSD95 antisense oligodeoxynucleotides (AS-ODNs) and missense-ODNs) was 5 0 -GAATGGGT CACCTCC-3 0 and 5 0 -CCGCTCTATCGAGGA-3 0 , respectively (Di et al. 2012) . These materials were constructed and verified by Sangon Biological Engineering Technology & Services Co., Ltd (Shanghai, China).
Sample preparation
For the hippocampal cultures, cells were directly scraped by shovels according to experiments. The sample was then centrifuged and the supernatant was removed; for epileptic rats, hippocampi were removed immediately after decapitation at different times of KA injection. After that, the CA1 and CA3 regions were isolated based on the methods with minor modifications (Coultrap et al. 2005; Chiu et al. 2007) . The samples were frozen in liquid nitrogen as quickly as possible. The samples were homogenized in ice-cold was measured by the biotin-switch assay, followed by western blotting analysis and nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate detection system. Bands were scanned, and the intensity was determined by optical density (OD) ratio of folds divided by the saline control. The data were expressed as mean AE SEM (n = 4, indicating four different cultures for each data). *p < 0.05 versus the saline control, # p < 0.05 versus KA groups. GluK2. Hippocampal cultures were pre-treated with 10 lΜ nifedipine (d), 10 lΜ tetracaine hydrochloride (TH) (e), and 10 lΜ thapsigargin (Thaps) (f), respectively. The inhibitors were added 30 min before KA treatment. SNO-GluK2 was measured by the biotin-switch assay, followed by western blotting analysis and nitro blue tetrazolium chloride/5-bromo-4-chloro-3-indolyl phosphate detection system. Bands were scanned, and the intensity was determined by OD ratio of folds divided by saline control. The data were expressed as mean AE SEM (n = 4, indicating four different cultures for each data). *p < 0.05 versus the saline control, # p < 0.05 versus KA groups.
homogenization buffer with protease inhibitor cocktail (Roche Diagnostics, Basel, Switzerland) and the homogenates were quantified by Bradford assays (Bio-Rad, Hercules, CA, USA). All procedures above were performed on ice.
Immunohistochemitry
For histological analysis, rats were perfusion-fixed with 4% paraformaldehyde solution under anesthesia after 7 days of KA injection. The brains were quickly excavated and post-fixed in 4% paraformaldehyde overnight at 4°C. The brains were transferred to ethanol at graded concentrations of 70-100% (v/v) for dehydration and then embedded in paraffin. After that, the brain tissues were coronally sectioned (5 lm thick) by a microtome (Leica RM2155, Germany, Wetzlar). The sections were de-paraffinized, rehydrated, and then stained with 0.1% (w/v) cresyl violet for 5 min. The neuronal damage in the hippocampus was observed by a light microscopy. The number of surviving hippocampal CA1 and CA3 pyramidal cells, 1 mm of length, was counted as the neuronal density. Transferase-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL) staining was conducted by an ApopTag1 Peroxidase in situ Apoptosis Detection Kit (Millipore, Bedford, MA, USA) according to the manufacturer's protocols. After deparaffinization and rehydration, the coronal sections were incubated with protease K (20 lg/mL) for 15 min at 25°C, and then treated with the reaction buffer containing terminal deoxynucleotidyltransferase at 37°C for 1 h. The sections were treated with antidigoxigenin conjugate for 30 min at 25°C immediately following the stop/wash buffer, and then developed color in peroxidase substrate. The nuclei were lightly counter-stained with 0.5% methyl green. The number of surviving or apoptotic hippocampal pyramidal cells in the CA1 and CA3/dentate gyrus area within 1 mm of length was counted as the neuronal density.
Immunoprecipitation
For immunoprecipitation, the homogenates (500 lg protein) were diluted fourfold with immunoprecipitation buffer, and subsequently incubated for 1 h with 20 ll of protein A-sepharose CL-4B (Amersham Biosciences, Uppsala, Sweden) at the temperature of 4°C. After removing proteins attached non-specifically to protein A, the supernatants were incubated with antibodies of target protein overnight at 4°C on a rotator: rabbit anti-GluK2/3 (#04-921; Millipore, RRID: AB_1587072), mouse anti-PSD95 (P246; Sigma, St Louis, MO, USA, RRID: AB_260911), and goat anti-nNOS (ab1376; Abcam, RRID:AB_300614). Protein A was added for 2-h incubation and then centrifuged at 10 000 g 9 2 min at 4°C. Immunoprecipitated proteins were eluted and used for sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Sample size calculation and inclusion/exclusion criteria The sample size was not predetermined by formal power analysis statistical methods. To reduce animal suffering, we chose the minimum sample size required for experiments in our study as reported previously (Benakis et al. 2016; Liu et al. 2017; Zhang et al. 2017) , which was described in each figure legends. There were two primary endpoints in our study. One was hours after KA injection for WB and immunoprecipitation (n = 4 rats of each group), and the other one was 7 days after KA for immunohistochemitry (n = 6 rats of each group). To ensure the availability of rats for each experiment in the end, the mortality and failure rate in seizures were considered. Animals under stage 3 seizures after KA treatment were excluded from the analysis. Because of 10% of total rats excluded, the initial number at the beginning of the study should be at least 110% of the final sample size. The timeline of the study design is detailed in Fig. 1 . The study was not pre-registered.
Statistical analysis
Observers were blinded to the grouping and experimental design during data collection and analysis. Data were expressed as mean AE SEM. The significance of difference among different treatments was obtained using one-way analysis of the variance (ANOVA), followed by the Duncan's new multiple range method or Newman-Keuls test. p < 0.05 was considered significant.
Results
KA induces an increase in SNO-GluK2 in a dose-and timedependent way in primary hippocampal cultures Incubation with KA in the hippocampal culture was previously used as a classic model of epilepsy in vitro (Bloss and Hunter 2010) . In our study, we first treated the hippocampal cultures with different KA concentrations, and measured the change in SNO-GluK2. We observed that KA induced a significant increase in SNO-GluK2, reaching a saturation response at 100 lΜ (Fig. 2a) . Next, we treated the culture with 100 lΜ KA for different times. The relative level of SNO-GluK2 began to increase markedly at 3 h, and reached a peak at 12 h after KA treatment (Fig. 2b) . Based on the dose-and time-dependent experiments, we chose the treatment of 100 lΜ KA for 12 h to examine SNO-GluK2 on the subsequent in vitro experiments. Thereafter, we wondered which kind of ionotropic glutamate receptors contribute to the S-nitrosylation. Since KA at the dose of 100 lΜ barely activates NMDARs (Huettner 1990; Lerma et al. 1993; Wilding and Huettner 1996) , we only considered the contribution of the two other ionotropic glutamate receptors, namely KARs and a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) to SNO-GluK2. As shown in Fig. 2(c) , KA-induced SNO-GluK2 has no significant changes after blocking AMPARs by 4-(8-Methyl-9H-1, 3-dioxolo [4, 5-h] [2, 3] benzodiazepin-5-yl)-benzenamine dihydrochloride (GYKI52466, an AMPAR antagonist.). In contrast, SNO-GluK2 induced by KA was largely reduced by 5-nitro-6, 7, 8, 9-tetrahydrobenzo[g] indole-2, 3-dione -3-oxime (NS-102, a specific antagonist of GluK2-KARs; Bleakman et al. 1999; Verdoorn et al. 1994) (Fig. 2d) . These results show that KA-induced SNO-GluK2 is majorly mediated by GluK2-KAR itself.
The production of SNO-GluK2 is associated with the level of cytoplasmic calcium in primary hippocampal cultures NO is produced by NOS, playing a crucial role in SNO of proteins. nNOS is the predominant isoform of NOS which is expressed constitutively in neurons (Hu and Zhu 2014) . As expected, 7-nitroindazole (7-NI), an inhibitor of nNOS (Teppema et al. 2000) , markedly reduced the production of SNO-GluK2 (Fig. 3a) . Next, we wanted to know whether calcium influx regulates SNO-GluK2. First, application of a calcium ionophore causing a considerable calcium rise (A23187) (Babcock et al. 1976; Wu et al. 2011) , substantially increased SNO-GluK2. The increase was blocked by 7-NI (Fig. 3b) . On the contrary, quenching of cytoplasmic-free calcium ([Ca 2+ ] i ) with 1,2-bis(o-aminophenoxy)ethane-N,N, N',N'-tetraacetic acid (BAPTA), a cytoplasmic calcium scavenger (Ricci et al. 1998) , dramatically reduced KAinduced SNO-GluK2 (Fig. 3c) . To further determine the contribution of different calcium entries, we applied nifedipine to block L-VGCCs (McDonald et al. 1994; Curtis and Scholfield 2001) and observed a significantly reduced SNOGluK2 (Fig. 3d) . It is known that RyRs and Ca 2+ -ATPase on ER are involved in regulation of cytoplasmic Ca 2+ level (Ouardouz et al. 2009; Guerrero-Hernandez et al. 2010) . We found that SNO-GluK2 induced by KA was markedly attenuated by Tetracaine hydrochloride (TH, a RyRs antagonist). Conversely, addition of thapsigargin, an inhibitor of the sarco-ER Ca 2+ -ATPase, boosted the SNO-GluK2 (Fig. 3e and f) . These results suggest that the level of cytoplasmic Ca 2+ affects KA-induced SNO-GluK2.
SNO-GluK2 affects ion channel characterization of GluK2-KARs in primary hippocampal cultures
For a detailed analysis of the functional characteristics of SNO-GluK2, the whole-cell patch clamp experiments were performed in neurons under different conditions as shown below. The current elicited by KA in the cultured hippocampal neurons was remarkably decreased after an addition of GYKI52466 (Fig. 4a) . To exclude the effects of AMPARs on currents, the cultures were treated by both KA and GYKI52466 in the subsequent experiments. As we speculated, the decrease in SNO-GluK2 in response to 7-NI significantly suppressed the currents induced by KA (Fig. 4b) . Meanwhile, the current mediated by GluK2-KARs were obviously enhanced in the presence of thapsigargin (Fig. 4c ), in parallel with elevation of SNO-GluK2. These findings imply that SNO-GluK2 improves the ion channel function of the GluK2-KARs.
GluK2-KARs mediated SNO-GluK2 in the rat hippocampus following KA administration
To explore the contribution of SNO-GluK2 to the pathogenesis of epilepsy, we examined SNO-GluK2 in the hippocampal CA1 and CA3 area in the KA-induced epileptic rats. The rat model of epilepsy was established by unilateral stereotaxic microinjection of KA (0.6 lg/10 ll) into the lateral ventricle (Zhang et al. 2011) . After the hippocampus was dissected, the CA1 and CA3 regions were isolated based on the methods with minor modifications (Coultrap et al. 2005; Chiu et al. 2007 ). SNO-GluK2 showed an obvious increase in both CA1 and CA3 area at 3 h after KA administration, reached a peak at 6 h, and then gradually declined (Fig. 5a ). Previous studies suggested that NMDARs or AMPARs may have less contribution to KA-induced epilepsy established by this protocol (Zhang et al. 2011 ), thus we focused on the role of GluK2-KARs. Pre-treatment with NS-102 blocked SNO-GluK2 at 6 h after KA (Fig. 5b) . Taken together, these data showed that SNO-GluK2 induced by its own activation was tightly associated with the epilepsy.
SNO-GluK2 is regulated by the level of cytoplasmic calcium in the hippocampal CA1 and CA3 area of epileptic rats after KA administration As in vitro experiments, SNO-GluK2 was greatly decreased by inhibition of nNOS with 7-NI (Fig. 6a) , or chelating cytoplasmic Ca 2+ with BAPTA ( Fig. 6b ) in CA1 and CA3 regions of the hippocampus in epileptic rats, indicating that SNO-GluK2 was generated by nNOS in a Ca 2+ -dependent manner. When calcium influx was blocked by inhibition of L-VGCCs with Nifedipine (Fig. 6c) , we found that SNOGluK2 was strongly reduced in the both two regions. Next, we manipulated the cytoplasmic calcium store by inhibiting RyRs with administration of TH or Ca 2+ -ATPase with administration of Thapsigargin. Consistent with the results from our in vitro experiments, the inhibition of RyRs resulted in a marked decrement of SNO-GluK2 (Fig. 6e) , whereas the inhibition of Ca 2+ -ATPase significantly boosted SNO-GluK2 in the hippocampal CA1 and CA3 regions (Fig. 6d) . Additionally, administration with 2-aminoethoxy-diphenyl borate, a calcium release modulator (Luciani et al. 2009; Patel et al. 2009 ), failed to influence SNO-GluK2 in the hippocampus (Fig. 6f) , presumably suggesting a less contribution of inositol 1,4,5-triphosphate receptors. Collectively, these data provided evidence that SNO-GluK2 is regulated by the cytoplasmic calcium level in KA-induced epilepsy.
Inhibition of SNO-GluK2 protects neurons from KA-induced death in the hippocampal CA1 and CA3 regions Seizures can lead to neuronal cell death in human patients and animal models (Chang and Lowenstein 2003; Rao and Lowenstein 2015) . To determine the role of SNO-GluK2 in KA-induced damage, we examined the survival and apoptosis of CA1 and CA3 pyramidal cells in the hippocampus by cresyl violet staining and TUNEL staining, respectively. Compared to the round and palely stained nuclei of shamoperated rats, there was a substantial loss of pyramidal cells in both CA1 and CA3 area after KA treatment. Inhibition of SNO-GluK2 with the pre-treatment of NS-102, 7-NI, BAPTA, Nifedipine, or TH dramatically reduced neuronal injury and loss (Fig. 7a) . Paralleled with the results of Cresyl ) 20 min prior to KA injection. SNO-GluK2 was measured by the biotin-switch assay, followed by western blotting analysis and enhanced chemiluminescence detection system. Bands were scanned, and the intensity was determined by OD ratio of folds divided by sham groups. The data were expressed as mean AE SEM (n = 4, indicating four different rats for each data). *p < 0.05 versus the sham groups, # p < 0.05 versus KA groups.
violet staining, a large number of TUNEL-positive cells were found in the KA-treated group characterized by shrunken condensed nuclei and apoptotic bodies. As compared with the KA group, the addition of NS-102, 7-NI, BAPTA, nifedipine, and TH markedly alleviated the neuronal apoptosis (Fig. 7b) . The above results suggested that SNO-GluK2 is associated with the progressive neuronal loss and apoptosis in the epilepsy.
Assembly of the GluK2-PSD95-nNOS signaling module during KA-induced seizure in hippocampal CA1 and CA3 area of rats There is evidence that nNOS can bind to GluK2 mediated by PSD95, a key scaffolding protein of post-synaptic density, forming GluK2-PSD95-nNOS signaling module (Yu et al. 2008; Chen et al. 2009; Di et al. 2012) . Furthermore, to verify the assembly of the module following KA-induced seizures, we performed immunoprecipitation and immunoblots experiments. Interestingly, we found that any two of GluK2, PSD95, and nNOS could interplay directly with each other (Fig. 8a) , indicating a physical association among GluK2, PSD95, and nNOS. Next, we used a short peptide (Tat-GluK2-9c) to perturb the interaction of the three proteins. Administration of Tat-GluK2-9c prior to KA markedly attenuated their interaction, whereas expressions of GluK2, PSD95, and nNOS were unaltered (Fig. 8b) . To further confirm their relationships, we knocked down PSD95 via PSD95 AS-ODNs. As illustrated in Fig. 8(c) , PSD95 AS-ODNs significantly reduced the expression of PSD95 and the interaction between GluK2 and nNOS 6 h after KA-induced seizure. In contrast, PSD95 missenseODNs failed to interrupt their interactions. Moreover, treatment of Tat-GluK2-9c or PSD95 AS-ODNs led to a significant reduction in the level of SNO-GluK2 (Fig. 8d and  e) . Together, these results revealed that assembly of GluK2-PSD95-nNOS signaling module might be implicated in the KA-induced epilepsy.
Discussion
There is evidence that GluK2-KARs play a vital role in epileptogenesis. In this study, we for the first time reported that GluK2 was S-nitrosylated at protein post-translational modification level in epilepsy and had close correlations with epilepsy-induced neuronal injury. Furthermore, we showed that SNO-GluK2 was regulated by the level of cytoplasmic calcium in the epileptogenesis. Finally, we suggested that the assembly of a GluK2-PSD95-nNOS signaling module might play a vital role in KA-induced epilepsy.
Previous studies showed that the generation of NO by activation of nNOS is triggered by the cytoplasmic Ca 2+ influx in a Ca 2+ /calmodulin-dependent manner (Hayashi et al. 1999; Song et al. 2004) . In this study, we established that SNO-GluK2 was regulated by the cytoplasmic calcium level indeed. Dramatic increase of cytoplasmic Ca 2+ concentration is often due to extracellular Ca 2+ overload or perturbation of cytoplasmic Ca 2+ compartmentalization (Petersen 2002) . As reported in the literature (Berridge et al. 2000; Petersen 2002; Szopa et al. 2013) , permeabilization of cytoplasmic membranes causes a rise in the level of cytoplasmic Ca 2+ by activating Ca 2+ influx across the cytoplasmic membrane. All NMDARs, AMAPRs, and KARs belong to ionotropic glutamate receptors, while their functions, especially on ion permeability, are quite different (Negrete-Diaz et al. 2007; Barker-Haliski and White 2015) . NMDARs are highly permeable to Ca 2+ , whereas opening of AMPARs and KARs only allows a small amount of calcium influx. Under our in vitro experimental condition, KA rarely activated NMDARs (Lerma et al. 1993; Wilding and Huettner 1996) , therefore, SNO-GluK2 predominately resulted from activation of KARs and AMPARs. However, NS-102 eliminated KA-mediated SNO-GluR6, while a specific blocker of AMPARs by GYKI52466 failed, suggesting that SNO-GluK2 was attributed to activation of KARs. These findings appeared to contradict with some studies reporting no effects of KA on cytosolic Ca 2+ (Kamiya and Ozawa 2000; Kamiya et al. 2002) , which obviously could not account for the essential Ca 2+ concentration for SNO-GluK2. Previous studies showed that the generation of NO by activation of nNOS is triggered by the cytoplasmic Ca 2+ influx in a Ca 2+ /calmodulin-dependent manner (Hayashi et al. 1999; Song et al. 2004) . Besides the ionotropic glutamate receptors, the influx of Ca 2+ through VGCCs, which can be activated by Na + influx and a small amount of Ca 2+ entry, is another major mechanism for the rise of cytoplasmic free Ca 2+ levels. (Letz et al. 1997; Ouardouz et al. 2003 Ouardouz et al. , 2009 Negrete-Diaz et al. 2006) . Our results showed that VGCCs is required for KA-induced SNOGluK2. Using a similar strategy, we further demonstrated the involvement of Ca 2+ release from Ca 2+ stores by activation of RyRs localized on the ER, which is dependent upon the depolarization and subsequent opening of L-VGCCs reported previously (Petersen 2002; Manita et al. 2011; Best and Kamp 2012; Andrade-Talavera et al. 2013) . As compared with TH, the calcium release modulator 2-aminoethoxydiphenyl borate failed to prevent enhancement of SNOGluK2, suggesting that IP 3 R-mediated Ca 2+ signaling may not be involved in the process of SNO-GluK2. Besides Ca 2+ signaling mentioned above, mitochondrial calcium efflux is an indispensable element for [Ca 2+ ] i elevation (Berridge et al. 2000; Nicholls 2005; Szopa et al. 2013; De Marchi et al. 2014) . Roles of mitochondrial Ca 2+ signaling implicated in SNO-GluK2 will be investigated in our future work. Taken together, SNO-GluK2 is not only regulated by L-VGCCs, but also affected via RyRs on the ER.
The magnitude of [Ca 2+ ] i increase is thought to determine both the amplitude and direction of SNO-GluK2 by nNOS activation of Ca 2+ -sensitive mediators such as calmodulin. (Thaps) (20 mM, 5 ll, i.c.v.), tetracaine hydrochloride (TH) (0.5 lg/5 ll, 2 lg/5 ll, 5 lg/5 ll, i.c.v.), or 2-aminoethoxy-diphenyl borate (2-APB) (10 nmol/5 ll, i.c.v.) before KA administration (0.6 lg/5 ll, i.c.v.), respectively. SNO-GluK2 was measured by the biotin-switch assay, followed by western blotting analysis and enhanced chemiluminescence detection system. Bands were scanned, and the intensity was determined by OD ratio of folds divided by sham groups. The data were expressed as mean AE SEM (n = 4, indicating four different rats for each data). *p < 0.05 versus the sham groups, # p < 0.05 versus KA groups.
The previous reports implicated a much closer association between GluK2 and nNOS (Ouardouz et al. 2009; Zhang et al. 2012) . GluK2 was demonstrated to be S-nitrosylated in I/R, which was coupled with nNOS, mixed lineage kinase 3 or Jun N-terminal kinase through PSD95, to form signaling complexes as downstream effectors (Yu et al. 2008; Di et al. 2012) . Consistently, our data showed that GluK2-nNOS-PSD95 was assembled as a signaling complex during seizure induced by KA in hippocampal both CA1 and CA3 regions (Fig. 8) , supporting a structural and functional connection between GluK2 and nNOS. Future studies are required to confirm the assembly of GluK2-PSD95-nNOS signaling module and to illustrate its detailed relationship with SNOGluK2.
Our electrophysiological recordings showed that function of KARs were significantly influenced by SNO-GluK2. Higher SNO-GluK2 represented larger currents. Notably, immunostaining results revealed a positive correlation between SNO-GluK2 and brain damage. Moreover, suppression of SNO-GluK2 by pharmacological methods greatly reduced the neuronal injury. Therefore, these data showed that SNO-GluK2 plays an important role in the KA-related epilepsy. Future work need to identify some critical cysteines for SNO-GluK2 by point mutation manipulation.
Based on our results, we proposed possible mechanisms for KA-induced epilepsy as illustrated in Fig. 9 : KA treatment activates GluK2, and subsequently leads to calcium influx, the release of internal calcium stores and excessive /calmodulin, activates neuronal nitric oxide synthase (nNOS) and subsequently produces NO from L-arginine, leading to SNO-GluK2, improving the coupling of GluK2-PSD95-nNOS signaling module, and eventually causing neuronal injury and death. Fig. 8 KA enhances the formation of kainate-type of ionotropic glutamate receptor 2 (GluK2)-PSD95-neuronal nitric oxide synthase (nNOS) signaling module in CA1 and CA3 regions of the rat hippocampus. (a) Assembly of GluK2-PSD95-nNOS signaling module in the hippocampus of the KA-treated rats. Proteins were immunoprecipitated with antiGluK2/PSD95/nNOS antibodies, respectively. IgG antibody was used as a negative control for immunoprecipitation and 30 lg of protein lysate was used as an input. (b) The effects of Tat-GluK2-9c on the interaction between PSD95 and nNOS. Tat-GluK2-9c peptide (100 lg/10 ll, saline) was administrated (i.c.v.) to the rats 30 min before KA infusion. (c) The effects of PSD95 expression on assembly of GluK2-PSD95-nNOS signaling module. The rats were administrated PSD95 AS-ODNs (10 nmol/10 lL, TE) every 24 h for 3 days via i.c.v. injection before KA treatment. The same dose of MS-ODNs or vehicle was used as control. Proteins were immunoprecipitated with anti-GluK2/PSD95/nNOS antibodies, respectively, and then immunoblotted with antibodies as shown in the figure. (d and e) Effects of Tat-GluK2-9c peptide and PSD95 ASODNs on KA-induced S-nitrosylation (SNO)-GluK2. Bands were scanned, and the intensity was determined by OD ratio of folds divided by sham groups. The data were expressed as mean AE SEM (n = 4, indicating four different rats for each data). *p < 0.05 versus the sham groups, # p < 0.05 versus KA groups.
nNOS-derived NO production, contributes to enormous SNO-GluK2, and ultimately neuronal loss and apoptosis. Upon activation of GluK2, nNOS may link to GluK2 by a mediator of PSD95 to assemble a GluK2-PSD95-nNOS signaling module, resulting in activation of a cascade of downstream signaling pathways, and eventually leading to epileptogenesis and neuronal damage. Together, our findings suggest that GluK2 is S-nitrosylated in response to NO and cytoplasmic Ca 2+ accumulation induced by KA, takes part in the assembly of GluK2-PSD95-nNOS. Our results establish an association between SNO-GluK2 and epilepsy. Together, this work will not only deepen the understanding of pathogenesis of epilepsy, but also provide a new target for epilepsy and other relevant neurological diseases.
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